TERM ID="NYU_TERM_1" STRING="New horizons" FREQUENCY=1 START=0 END=12 LEMMA="NEW HORIZON" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Specific areas" FREQUENCY=1 START=251 END=265 LEMMA="SPECIFIC AREA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="V2 receptor antagonists" FREQUENCY=1 START=64 END=87 LEMMA="V2 RECEPTOR ANTAGONIST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="clinical outcomes" FREQUENCY=1 START=643 END=660 LEMMA="CLINICAL OUTCOME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="clinical practice" FREQUENCY=1 START=232 END=249 LEMMA="CLINICAL PRACTICE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="clinical rationale" FREQUENCY=1 START=305 END=323 LEMMA="CLINICAL RATIONALE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="correcting hyponatremia" FREQUENCY=1 START=606 END=629 LEMMA="CORRECTING HYPONATREMIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="hyponatremia" FREQUENCY=1 START=216 END=228 LEMMA="HYPONATREMIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="including advantages" FREQUENCY=1 START=362 END=382 LEMMA="INCLUDING ADVANTAGE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="including issues" FREQUENCY=1 START=494 END=510 LEMMA="INCLUDING ISSUE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="including issues of tolerability" FREQUENCY=1 START=494 END=526 LEMMA="TOLERABILITY INCLUDING ISSUE" LEMMA_FREQUENCY=1 HEAD_TERM="including issues" HEAD_LEMMA="INCLUDING ISSUE"
TERM ID="NYU_TERM_12" STRING="overview" FREQUENCY=1 START=113 END=121 LEMMA="OVERVIEW" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="pharmacologic approach" FREQUENCY=1 START=20 END=42 LEMMA="PHARMACOLOGIC APPROACH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="practical limitations" FREQUENCY=1 START=441 END=462 LEMMA="PRACTICAL LIMITATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="receptor antagonists" FREQUENCY=1 START=164 END=184 LEMMA="RECEPTOR ANTAGONIST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="therapeutic modalities" FREQUENCY=1 START=412 END=434 LEMMA="THERAPEUTIC MODALITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="tolerability" FREQUENCY=1 START=514 END=526 LEMMA="TOLERABILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="vaptans" FREQUENCY=1 START=186 END=193 LEMMA="VAPTAN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="vasopressin" FREQUENCY=1 START=150 END=161 LEMMA="VASOPRESSIN" LEMMA_FREQUENCY=1
